CMS proposes cutting 340B drug payments in 2027 OPPS rule
CMS has released the proposed 2027 Outpatient Prospective Payment System (OPPS) rule, including a proposal to reduce reimbursement for 340B-acquired drugs. The agency also intends to expand site-neutral payment policies. The proposed rule details the agency's payment update for next year. The comment period will open upon formal publication in the Federal Register. Hospital billing managers should monitor the final rule, expected in November, to model the financial impact on outpatient drug revenue.